NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

智慧胰島素筆針的全球市場分析:未來預測 (到2027年)

Global Smart Insulin Pens Market Research Report-Forecast till 2027

出版商 Market Research Future 商品編碼 975899
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
智慧胰島素筆針的全球市場分析:未來預測 (到2027年) Global Smart Insulin Pens Market Research Report-Forecast till 2027
出版日期: 2020年08月01日內容資訊: 英文 81 Pages
簡介

全球智慧胰島素筆針的市場規模,2019年達到7297萬美元,預計2020年∼2027年以10.77%的年複合成長率成長。市場主要促進因素,是糖尿病的患病人數增加,及產品陸續的認證、上市,操作容易,比胰島素幫浦經濟的選擇廣泛等。另一方面,非侵襲藥物遞輸系統的普及也有可能妨礙市場成長。

本報告提供全球智慧胰島素筆針的市場相關分析,產業的基本結構和向心力,技術、法規環境,主要的推動及阻礙市場要素,各產品種類、各流通管道、各地區的市場趨勢預測 (2027年),主要企業的簡介、業績、策略等調查。

目錄

第1章 摘要整理

第2章 市場概要

第3章 分析方法

第4章 市場動態

  • 概要
  • 推動市場要素
    • 糖尿病的盛行率的上升
    • 有力產品的上市與核准
    • 老年人口,久坐的生活方式風格,不健康的飲食增加
    • 對糖尿病治療的啟發活動和資金提供
  • 阻礙市場要素
    • 非侵入性藥物遞輸系統的普及
  • 市場機會
    • 未開發的市場

第5章 市場要素分析

  • 波特的五力分析
  • 價值鏈分析
    • 研究開發、設計
    • 製造
    • 流通與銷售
    • 售後服務/監測
  • 全球胰島素筆針市場上新型冠狀病毒感染疾病 (COVID-19)的影響

第6章 智慧胰島素筆針市場:各產品種類

  • 概要
  • 智慧筆
  • 連接設備

第7章 智慧胰島素筆針市場:各流通管道

  • 概要
  • 醫院藥局/零售藥局
  • 線上

第8章 全球智慧胰島素筆針市場:各地區

  • 概要
  • 南北美洲
    • 各產品種類
    • 各流通管道
    • 北美 (美國,加拿大)
    • 南美
  • 歐洲
    • 西歐 (德國,法國,英國,義大利,西班牙等)
    • 東歐
  • 亞太地區 (中國,日本,印度,澳洲,韓國等)
  • 中東、非洲

第9章 競爭情形

  • 概要
  • 主要企業
  • 企業間的互相比較
  • 企業儀表板
  • 市場主要成長策略
  • 代表性企業 - 從策略展開趨勢的觀點
  • 近來的主要趨勢分析
    • 事業合作
    • 產品的銷售
    • 事業聯盟 (夥伴關係)
    • 產品認證
    • 事業擴張

第10章 企業簡介

  • COMPANION MEDICAL
  • ELI LILY AND COMPANY
  • DIAMESCO CO., LTD
  • YPSOMED HOLDING AG
  • EMPERRA GMBH E-HEALTH TECHNOLOGIES
  • DIGITAL MEDICS PTY LTD
  • NOVO NORDISK A/S

第11章 附錄

目錄

Market Overview

Global Smart Insulin Pens Market accounted for USD 72.97 Million in 2019 and is evaluated to exhibit a CAGR of 10.77% during the projected timeframe of 2020 to 2027. The advanced technologies and inventions in the healthcare sector have led to the evolution of smart insulin pens. It is beneficial for both patients' poor insulin adherence, incorrect insulin initiation, and medication errors. These pens are used for external insulin delivery and offer an accessible solution to diabetes management. The adoption of smart insulin pens is increasing owing to the growing prevalence of diabetic patients, user-friendly operation, and the economic option as compared to insulin pumps.

Global Smart Insulin Pens Market is expected to witness a tremendous surge during the review period owing to the rising cases of diabetes, increasing product launches and approvals, growing geriatric population, sedentary lifestyle, and unhealthy diet, and increasing awareness and funding for the treatment of diabetes. As per the International Diabetes Federation (IDF), more than 1.1 million children and adolescents were living with type 1 diabetes worldwide in 2019. However, the increasing adoption of non-invasive drug delivery systems is expected to restrain market growth during the review period.

Market Segmentation

Global Smart Insulin Pens Market has been bifurcated based on Product Type and End User.

Based on product type, the market is categorized into a smartpen and connecting device.

By end-user category, the market is segmented into hospital/retail pharmacies and online.

Regional Analysis

Geographically, Global Smart Insulin Pens Market has been classified into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas is likely to drive the biggest market owing to the faster uptake of medicines & diagnostic measures by affected patients, and the advanced medical device industry in the region. Furthermore, the regional market growth is driven by various growth strategies, such as partnerships, collaborations, and advancement in the field of disease management creates awareness of products in medical professionals and patients. Europe is expected to drive the second-largest market share of the global smart insulin pens market followed by Asia-Pacific. The regional market growth is expected to drive the new product approvals and the existence of well-established healthcare infrastructure in many European countries.

Asia-Pacific is expected to be the fastest-growing market in the global market due to the increasing penetration of the diagnostic health sector, increasing awareness regarding pen needles, the rising number of a campaigns associated with smart insulin pens, and the rising prevalence of diabetes patients in this region. The smart insulin pens market in Middle East & Africa is estimated to witness stable market expansion during the study period owing to rising strategic initiatives by private and public firms and organizations.

Major Players

The Key Players in the Global Smart Insulin Pens Market are Companion Medical, Eli Lily and Company, Diamesco Co., Ltd., Ypsomed Holding AG, Emperra GmbH E-Health Technologies, Digital Medics Pty Ltd. and Novo Nordisk A/S.

COVID 19 Impacts

We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION 12
  • 2.2 SCOPE OF THE STUDY 12
  • 2.3 RESEARCH OBJECTIVE 12
  • 2.4 MARKET STRUCTURE 12
  • 2.5 ASSUMPTIONS & LIMITATIONS 13

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING 14
  • 3.2 SECONDARY RESEARCH 15
  • 3.3 PRIMARY RESEARCH 16
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 17
  • 3.5 FORECASTING TECHNIQUES 17
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 18
    • 3.6.1 BOTTOM-UP APPROACH 19
    • 3.6.2 TOP-DOWN APPROACH 19
  • 3.7 DATA TRIANGULATION 20
  • 3.8 VALIDATION 20

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 21
  • 4.2 DRIVERS 21
    • 4.2.1 GROWING PREVALENCE OF DIABETES 21
    • 4.2.2 RISING PRODUCT LAUNCHES AND APPROVALS 22
    • 4.2.3 INCREASING GERIATRIC POPULATION, SEDENTARY LIFESTYLE, AND UNHEALTHY DIET 22
    • 4.2.4 GROWING AWARENESS AND FUNDING FOR THE TREATMENT OF DIABETES 23
  • 4.3 RESTRAINTS 23
    • 4.3.1 RISING ADOPTION OF NON-INVASIVE DRUG DELIVERY SYSTEMS 23
  • 4.4 OPPORTUNITIES 24
    • 4.4.1 UNTAPPED MARKETS 24

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL 25
    • 5.1.1 BARGAINING POWER OF SUPPLIERS 26
    • 5.1.2 BARGAINING POWER OF BUYERS 26
    • 5.1.3 THREAT OF NEW ENTRANTS 26
    • 5.1.4 THREAT OF SUBSTITUTES 26
    • 5.1.5 INTENSITY OF RIVALRY 26
  • 5.2 VALUE CHAIN ANALYSIS 27
    • 5.2.1 R&D AND DESIGNING 28
    • 5.2.2 MANUFACTURING 28
    • 5.2.3 DISTRIBUTION & SALE 28
    • 5.2.4 POST-SALES MONITORING 28
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL SMART INSULIN PENS MARKET 29

6 SMART INSULIN PENS MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW 31
  • 6.2 SMART PEN 32
  • 6.3 CONNECTING DEVICE 33

7 SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

  • 7.1 OVERVIEW 34
  • 7.2 HOSPITAL/RETAIL PHARMACIES 35
  • 7.3 ONLINE 36

8 GLOBAL SMART INSULIN PENS MARKET, BY REGION

  • 8.1 OVERVIEW 37
  • 8.2 AMERICAS 38

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.2.1 NORTH AMERICA 39

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.2.1.1 US 40

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.2.1.2 CANADA 41

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.2.2 SOUTH AMERICA 42

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

  • 8.3 EUROPE 43

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.3.1 WESTERN EUROPE 44

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.3.1.1 GERMANY 46

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.3.1.2 FRANCE 46

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.3.1.3 UK 47

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.3.1.4 ITALY 47

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.3.1.5 SPAIN 48

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

      • 8.3.1.6 REST OF WESTERN EUROPE 48

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.3.2 EASTERN EUROPE 49

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

  • 8.4 ASIA-PACIFIC 50

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.4.1 CHINA 51

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.4.2 JAPAN 52

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.4.3 INDIA 52

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.4.4 AUSTRALIA 53

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.4.5 SOUTH KOREA 53

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.4.6 REST OF ASIA-PACIFIC 54

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

  • 8.5 MIDDLE EAST & AFRICA 55

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.5.1 MIDDLE EAST 56

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

    • 8.5.2 AFRICA 57

SMART INSULIN PENS MARKET, BY PRODUCT TYPE

SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW 58
  • 9.2 MAJOR PLAYERS IN THE GLOBAL SMART INSULIN PENS MARKET 58
  • 9.3 COMPETITIVE BENCHMARKING 60
  • 9.4 COMPETITOR DASHBOARD 61
  • 9.5 MAJOR GROWTH STRATEGIES IN THE GLOBAL SMART INSULIN PENS MARKET 62
  • 9.6 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL SMART INSULIN PENS MARKET 63
  • 9.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 63
    • 9.7.1 COLLABORATIONS 64
    • 9.7.2 LAUNCHES 64
    • 9.7.3 PARTNERSHIPS 64
    • 9.7.4 APPROVALS 65
    • 9.7.5 EXPANSIONS 65

10 COMPANY PROFILES

  • 10.1 COMPANION MEDICAL 66
    • 10.1.1 COMPANY OVERVIEW 66
    • 10.1.2 FINANCIAL OVERVIEW 66
    • 10.1.3 PRODUCTS/SERVICES OFFERED 66
    • 10.1.4 KEY DEVELOPMENTS 66
    • 10.1.5 SWOT ANALYSIS 67
    • 10.1.6 KEY STRATEGIES 67
  • 10.2 ELI LILY AND COMPANY 68
    • 10.2.1 COMPANY OVERVIEW 68
    • 10.2.2 FINANCIAL OVERVIEW 68
    • 10.2.3 PRODUCTS/SERVICES OFFERED 69
    • 10.2.4 KEY DEVELOPMENTS 69
    • 10.2.5 SWOT ANALYSIS 69
    • 10.2.6 KEY STRATEGIES 69
  • 10.3 DIAMESCO CO., LTD 70
    • 10.3.1 COMPANY OVERVIEW 70
    • 10.3.2 FINANCIAL OVERVIEW 70
    • 10.3.3 PRODUCTS/SERVICES OFFERED 70
    • 10.3.4 KEY DEVELOPMENTS 70
    • 10.3.5 SWOT ANALYSIS 71
    • 10.3.6 KEY STRATEGIES 71
  • 10.4 YPSOMED HOLDING AG 72
    • 10.4.1 COMPANY OVERVIEW 72
    • 10.4.2 FINANCIAL OVERVIEW 72
    • 10.4.3 PRODUCTS/SERVICES OFFERED 73
    • 10.4.4 KEY DEVELOPMENTS 73
    • 10.4.5 SWOT ANALYSIS 73
    • 10.4.6 KEY STRATEGIES 73
  • 10.5 EMPERRA GMBH E-HEALTH TECHNOLOGIES 74
    • 10.5.1 COMPANY OVERVIEW 74
    • 10.5.2 FINANCIAL OVERVIEW 74
    • 10.5.3 PRODUCTS/SERVICES OFFERED 74
    • 10.5.4 KEY DEVELOPMENTS 74
    • 10.5.5 SWOT ANALYSIS 75
    • 10.5.6 KEY STRATEGIES 75
  • 10.6 DIGITAL MEDICS PTY LTD 76
    • 10.6.1 COMPANY OVERVIEW 76
    • 10.6.2 FINANCIAL OVERVIEW 76
    • 10.6.3 PRODUCTS/SERVICES OFFERED 76
    • 10.6.4 KEY DEVELOPMENTS 76
    • 10.6.5 SWOT ANALYSIS 77
    • 10.6.6 KEY STRATEGIES 77
  • 10.7 NOVO NORDISK A/S 78
    • 10.7.1 COMPANY OVERVIEW 78
    • 10.7.2 FINANCIAL OVERVIEW 78
    • 10.7.3 PRODUCTS/SERVICES OFFERED 79
    • 10.7.4 KEY DEVELOPMENTS 79
    • 10.7.5 SWOT ANALYSIS 80
    • 10.7.6 KEY STRATEGIES 80

11 APPENDIX

  • 11.1 REFERENCES 81
  • 11.2 RELATED REPORTS 81

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 13
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 16
  • TABLE 3 NUMBER OF ADULTS (20-79 YEARS) WITH DIABETES WORLDWIDE (MILLION) 22
  • TABLE 4 GLOBAL SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 31
  • TABLE 5 GLOBAL SMART INSULIN PENS MARKET, FOR SMART PEN, BY REGION, 2016-2027 (USD MILLION) 32
  • TABLE 6 GLOBAL SMART INSULIN PENS MARKET, FOR CONNECTING DEVICE, BY REGION, 2016-2027 (USD MILLION) 33
  • TABLE 7 GLOBAL SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 34
  • TABLE 8 GLOBAL SMART INSULIN PENS MARKET, FOR HOSPITAL/RETAIL PHARMACIES, BY REGION, 2016-2027 (USD MILLION) 35
  • TABLE 9 GLOBAL SMART INSULIN PENS MARKET, FOR ONLINE, BY REGION,2016-2027 (USD MILLION) 36
  • TABLE 10 GLOBAL SMART INSULIN PENS MARKET, BY REGION 2016-2027 (USD MILLION) 37
  • TABLE 11 AMERICAS SMART INSULIN PENS MARKET, BY REGION, 2016-2027 (USD MILLION) 38
  • TABLE 12 AMERICAS SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 38
  • TABLE 13 AMERICAS SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 39
  • TABLE 14 NORTH AMERICA SMART INSULIN PENS MARKET, BY REGION, 2016-2027 (USD MILLION) 39
  • TABLE 15 NORTH AMERICA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 40
  • TABLE 16 NORTH AMERICA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 40
  • TABLE 17 US SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 40
  • TABLE 18 US SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 41
  • TABLE 19 CANADA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 41
  • TABLE 20 CANADA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 41
  • TABLE 21 SOUTH AMERICA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 42
  • TABLE 22 SOUTH AMERICA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 42
  • TABLE 23 EUROPE SMART INSULIN PENS MARKET, BY REGION, 2016-2027 (USD MILLION) 43
  • TABLE 24 EUROPE SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 44
  • TABLE 25 EUROPE SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 44
  • TABLE 26 WESTERN EUROPE SMART INSULIN PENS MARKET, BY REGION, 2016-2027 (USD MILLION) 44
  • TABLE 27 WESTERN EUROPE SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 45
  • TABLE 28 WESTERN EUROPE SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 45
  • TABLE 29 GERMANY SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 46
  • TABLE 30 GERMANY SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 46
  • TABLE 31 FRANCE SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 46
  • TABLE 32 FRANCE SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 46
  • TABLE 33 UK SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 47
  • TABLE 34 UK SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 47
  • TABLE 35 ITALY SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 47
  • TABLE 36 ITALY SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 47
  • TABLE 37 SPAIN SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 48
  • TABLE 38 SPAIN SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 48
  • TABLE 39 REST OF WESTERN EUROPE SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 48
  • TABLE 40 REST OF WESTERN EUROPE SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 49
  • TABLE 41 EASTERN EUROPE SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 49
  • TABLE 42 EASTERN EUROPE SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 49
  • TABLE 43 ASIA-PACIFIC SMART INSULIN PENS MARKET, BY COUNTRY, 2016-2027 (USD MILLION) 50
  • TABLE 44 ASIA-PACIFIC SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 51
  • TABLE 45 ASIA-PACIFIC SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 51
  • TABLE 46 CHINA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 51
  • TABLE 47 CHINA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 51
  • TABLE 48 JAPAN SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 52
  • TABLE 49 JAPAN SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 52
  • TABLE 50 INDIA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 52
  • TABLE 51 INDIA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 52
  • TABLE 52 AUSTRALIA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 53
  • TABLE 53 AUSTRALIA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 53
  • TABLE 54 SOUTH KOREA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 53
  • TABLE 55 SOUTH KOREA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 53
  • TABLE 56 REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 54
  • TABLE 57 REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 54
  • TABLE 58 MIDDLE EAST & AFRICA SMART INSULIN PENS MARKET, BY REGION 2016-2027 (USD MILLION) 55
  • TABLE 59 MIDDLE EAST & AFRICA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 55
  • TABLE 60 MIDDLE EAST & AFRICA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 56
  • TABLE 61 MIDDLE EAST SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 56
  • TABLE 62 MIDDLE EAST SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 56
  • TABLE 63 AFRICA SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2016-2027 (USD MILLION) 57
  • TABLE 64 AFRICA SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2016-2027 (USD MILLION) 57
  • TABLE 65 PRODUCT OVERVIEW OFFERED BY MAJOR PLAYERS IN THE SMART INSULIN PENS MARKET 60
  • TABLE 66 THE MOST ACTIVE PLAYER IN THE GLOBAL SMART INSULIN PENS MARKET 63
  • TABLE 67 COLLABORATIONS 64
  • TABLE 68 LAUNCHES 64
  • TABLE 69 PARTNERSHIPS 64
  • TABLE 70 APPROVALS 65
  • TABLE 71 EXPANSIONS 65
  • TABLE 72 COMPANION MEDICAL: PRODUCTS/SERVICES OFFERED 66
  • TABLE 73 COMPANION MEDICAL: KEY DEVELOPMENTS 66
  • TABLE 74 ELI LILY AND COMPANY: PRODUCTS/SERVICES OFFERED 69
  • TABLE 75 DIAMESCO CO., LTD: PRODUCTS/SERVICES OFFERED 70
  • TABLE 76 YPSOMED HOLDING AG: PRODUCTS/SERVICES OFFERED 73
  • TABLE 77 EMPERRA GMBH E-HEALTH TECHNOLOGIES: PRODUCTS/SERVICES OFFERED 74
  • TABLE 78 EMPERRA GMBH E-HEALTH TECHNOLOGIES: KEY DEVELOPMENTS 74
  • TABLE 79 DIGITAL MEDICS PTY LTD: PRODUCTS/SERVICES OFFERED 76
  • TABLE 80 NOVO NORDISK A/S: PRODUCTS/SERVICES OFFERED 79
  • TABLE 81 NOVO NORDISK A/S: KEY DEVELOPMENTS 79

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 11
  • FIGURE 2 GLOBAL SMART INSULIN PENS MARKET STRUCTURE 12
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 19
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL SMART INSULIN PENS MARKET 21
  • FIGURE 5 DRIVER IMPACT ANALYSIS 23
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS 24
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL SMART INSULIN PENS MARKET 25
  • FIGURE 8 VALUE CHAIN: GLOBAL SMART INSULIN PENS MARKET 27
  • FIGURE 9 GLOBAL SMART INSULIN PENS MARKET, BY PRODUCT TYPE, 2019 & 2027 (USD MILLION) 32
  • FIGURE 10 GLOBAL SMART INSULIN PENS MARKET, BY DISTRIBUTION CHANNEL, 2019 & 2027 (USD MILLION) 35
  • FIGURE 11 GLOBAL SMART INSULIN PENS MARKET SHARE, BY REGION 2019 (%) 37
  • FIGURE 12 AMERICAS SMART INSULIN PENS MARKET SHARE, BY REGION, 2019 (%) 38
  • FIGURE 13 NORTH AMERICA SMART INSULIN PENS MARKET SHARE, BY COUNTRY, 2019 (%) 39
  • FIGURE 14 EUROPE SMART INSULIN PENS MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 43
  • FIGURE 15 WESTERN EUROPE SMART INSULIN PENS MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 45
  • FIGURE 16 ASIA-PACIFIC SMART INSULIN PENS MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 50
  • FIGURE 17 MIDDLE EAST & AFRICA SMART INSULIN PENS MARKET SHARE, BY COUNTRY/REGION, 2019 (%) 55
  • FIGURE 18 MAJOR PLAYERS MARKET SHARE ANALYSIS IN THE GLOBAL SMART INSULIN PENS MARKET 2019 (%) 58
  • FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS 60
  • FIGURE 20 COMPETITOR DASHBOARD: GLOBAL SMART INSULIN PENS MARKET 61
  • FIGURE 21 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN THE GLOBAL SMART INSULIN PENS MARKET 62
  • FIGURE 22 GLOBAL SMART INSULIN PENS MARKET, KEY DEVELOPMENTS & GROWTH STRATEGIES (%) 63
  • FIGURE 23 COMPANION MEDICAL: SWOT ANALYSIS 67
  • FIGURE 24 ELI LILY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 68
  • FIGURE 25 ELI LILY AND COMPANY: SWOT ANALYSIS 69
  • FIGURE 26 DIAMESCO CO., LTD: SWOT ANALYSIS 71
  • FIGURE 27 YPSOMED HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT 72
  • FIGURE 28 YPSOMED HOLDING AG: SWOT ANALYSIS 73
  • FIGURE 29 THIS IS A PRIVATELY HELD COMPANY. HENCE, THE FINANCIAL INFORMATION IS NOT AVAILABLE IN THE PUBLIC DOMAIN. 74
  • FIGURE 30 EMPERRA GMBH E-HEALTH TECHNOLOGIES: SWOT ANALYSIS 75
  • FIGURE 31 DIGITAL MEDICS PTY LTD: SWOT ANALYSIS 77
  • FIGURE 32 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT 78
  • FIGURE 33 NOVO NORDISK A/S: SWOT ANALYSIS 80